Name
PANEL: Breaking Down the Major Challenges of Manufacturing Defined Consortia of LBPS. Including Process Development Optimization, Meeting CGMP Manufacturing Requirements and Quality Control Practices.
Date & Time
Thursday, June 4, 2020, 12:05 PM - 12:40 PM
Speakers
Dan Couto - Vedanta Biosciences
Bharat Dixit - Artugen Therapeutics
Adrien Nivoliez - Biose Industrie
Sarah Garant - Seres Therapeutics, Inc
Dan Couto Bharat Dixit Adrien Nivoliez Sarah Garant
Description

• Understand how our speakers are controlling the costs of goods for LBPs in phase 1 and 2.

• Assess the latest methods to avoid pathogen presence in final LBP product.

• In-house or CDMO? With manufacturing not being a core competency of microbiome companies, what are the implications of both business models and which is best for your company?

• How can you implement better analytics for quality control (including PCR and flow cytometry) to replace classical approaches like microscopy and CFU count?

Session Type
Panel
Virtual Session Link
View Session
Session Themes
Manufacturing
On Demand
https://vimeo.com/426938293/f800c3aa5a